The American Society of Health-System Pharmacists has conducted a survey of more than 2,800 hospital pharmacy directors in the U.S. about how the flu vaccine shortage is affecting their ability to care for patients.
As of Oct. 12, 2004 nearly 650 pharmacy directors have responded. The survey will continue through midnight today.
Preliminary findings include:
-- In just the few days since the influenza vaccine shortage was announced, more than 55 percent of respondents report that they have been contacted by opportunistic vendors offering to sell flu vaccine at highly inflated prices.
Of the hospitals contacted by opportunistic vendors:
- - More than 80 percent report being offered the vaccine at more than four times the original market value.
- - Nearly 20 percent have been offered the vaccine at $800 or more per 10-dose vial -- more than 10 times the original market value
- More than 75 percent of hospitals report that they will not have enough flu vaccine to meet the vaccination recommendations of the Centers for Disease Control and Prevention (CDC).
Source: American Society of Health-System Pharmacists (ASHP)
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.